Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis.
<h4>Background/objective</h4>Vascular endothelial growth factor (VEGF) is the most important promotor of angiogenesis. Some studies indicate that anti-angiogenic agents that interfere with VEGF and its receptor (VEGFR), i.e., anti-VEGF/VEGFR agents, may be applied to treat endometriosis....
Saved in:
| Main Authors: | Shuangge Liu, Xiaoyan Xin, Teng Hua, Rui Shi, Shuqi Chi, Zhishan Jin, Hongbo Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0166658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunohistochemical study of VEGF-A, VEGFR-1, VEGFR-2 and CD34 expression in сolorectal adenocarcinoma progression
by: M. A. Shyshkin
Published: (2019-09-01) -
Anti-Angiogenic Potential of Marine <i>Streptomyces</i>-Derived Lucknolide A on VEGF/VEGFR2 Signaling in Human Endothelial Cells
by: Byeoung-Kyu Choi, et al.
Published: (2025-02-01) -
Progress on the HIF-1α/VEGF/VEGFR2 signal pathway in hepatic alveolar echinococcosis
by: Meng-Zhao Xu, et al.
Published: (2025-04-01) -
Linking preclinical models to clinical realities: VEGF/VEGFR inhibitors and thrombotic microangiopathy in cancer therapy
by: Aimin Jiang, et al.
Published: (2025-06-01) -
Role of Anti VEGF Agent in Management of Primary Pterygium
by: Abhinav Singh, et al.
Published: (2018-10-01)